Evidence map›Paper›PMID 32252235›Full record

ArticleBiomolecules2020

Rajendran Jeyasri, Pandiyan Muthuramalingam, Vellaichami Suba, Manikandan Ramesh, Jen-Tsung Chen

Open access · goldAbstract read
In one paragraph

Article in Biomolecules, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed
18.1field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 117 citations in OpenAlex.

  1. Review
  2. Review
  3. The Role ofNutrients · 2025
    Review
  4. Article
  5. Article
  6. Review
  7. Review
  8. Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Review
  14. Review
  15. ComprehensiveFrontiers in microbiology · 2024
    Article
  16. InvestigatingCurrent pharmaceutical design · 2024
    Review
  17. Article
  18. Network pharmacology: a systems perspective possible underpinning approach for oral cancer treatment.Daru : journal of Faculty of Pharmacy, Tehran University of Medical Sciences · 2023
    Article
  19. Therapeutic Candidates for Alzheimer's Disease: Saponins.International journal of molecular sciences · 2023
    Review
  20. Depression and Its Phytopharmacotherapy-A Narrative Review.International journal of molecular sciences · 2023
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 2 countries.

Rajendran JeyasriDepartment of Biotechnology, Science Campus, Alagappa University, Karaikudi 630 003, India.ORCID 0000-0002-0096-338X
Pandiyan MuthuramalingamDepartment of Biotechnology, Science Campus, Alagappa University, Karaikudi 630 003, India.ORCID 0000-0001-7294-1625
Vellaichami SubaDepartment of Biotechnology, Science Campus, Alagappa University, Karaikudi 630 003, India.
Manikandan RameshDepartment of Biotechnology, Science Campus, Alagappa University, Karaikudi 630 003, India.ORCID 0000-0002-7969-4935
Jen-Tsung ChenDepartment of Life Sciences, National University of Kaohsiung, Kaohsiung 811, Taiwan.ORCID 0000-0002-3540-4449
Alagappa University · INNational University of Kaohsiung · TW

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Neurological diseases (NDs), especially Alzheimer's and Spinocerebellar ataxia (SCA), can severely cause biochemical abnormalities in the brain, spinal cord and other nerves of human beings. Their ever-increasing prevalence has led to a demand for new drug development. Indian traditional and Ayurvedic medicine used to combat the complex diseases from a holistic and integrative point of view has shown efficiency and effectiveness in the treatment of NDs.

Indexed as

CheminformaticsMolecular Targeted TherapySystems BiologyBacopaGene OntologyHumansNervous System DiseasesPlant ExtractsPlant ExtractsAlzheimer’s diseaseBacopa monnieribioactive compoundscheminformaticsneurological diseasesspinocerebellar ataxiasystem pharmacology

Identifiers

PMID32252235
PMCPMC7225932
OpenAlexW3014537365

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.